Giles AI has raised £750k in pre-seed funding from angel investors and strategic backer Regulatory Scientific and Health Solutions, who support the biopharma industry with scientific data solutions and regulatory consultancy.
Giles AI supports faster, smarter, and more compliant decision-making by delivering an AI-powered tool that enhances workflows in medical research, clinical trials, regulatory affairs, public health, CRO services and healthcare academia. The conversational AI platform connects to global healthcare data to enable organisations to access real-time insights and accelerate their research, all within a single, efficient ecosystem.
Founded by Rishi Wadhera, Shahir Raja and Constantin Gorgan, Giles AI recently struck a deal with Google and is poised to scale its product and expand its reach across the healthcare sector where smarter workflows and evidence-based innovation are critical. The new capital will support product development, hiring, and go-to-market activities, as the company enters its next phase of growth.
The round was completed through the FounderCatalyst platform, a cost-effective and rapid fundraising solution tailored for early-stage startups.
